Crossmark

MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cells

Crossref DOI link: https://doi.org/10.1186/s12885-018-4600-6

Published Online: 2018-07-05

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yoon, Yi Na

Choe, Min Ho

Jung, Kwan-Young

Hwang, Sang-Gu

Oh, Jeong Su

Kim, Jae-Sung http://orcid.org/0000-0002-8017-4515
Funding

Funding for this research was provided by:

a grant of the Korea Institute of Radiological and Medical Sciences(KIRAMS), funded by Ministry of Science and ICT(MSIT), Republic of Korea (50531-2018)

the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (HA17C0028)
License Information

Text and Data Mining valid from 2018-07-05
More Information

Article History

Received: 12 March 2018

Accepted: 15 June 2018

First Online: 5 July 2018

Ethics approval and consent to participate

: All patients gave signed, informed consent for their participation in scientific research. This study was approved by the ethics committee of Korea Institute of Radiological and Medical Sciences (IRB number: K-1504-002-044).

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.